Humacyte (HUMA) Non-Current Debt (2020 - 2025)
Humacyte's Non-Current Debt came in at $17.67 million for Q3 2025, down 71.5% from $62.12 million a year earlier and down 73.4% from the prior quarter.
Powered by 
Analysis
Humacyte (HUMA) Non-Current Debt (2020 - 2025) Analysis & Trends
At the end of FY2024, Humacyte's Non-Current Debt was $63.35 million, up 64.1% from FY2023.
- Non-Current Debt carries a four-year compound annual growth rate of 196.3% (FY2020 to FY2024).
- Going back by year, Non-Current Debt was $38.6 million in FY2023 (+89.8%), $20.34 million in FY2022 (-25.7%), $27.36 million in FY2021 and $822,000 in FY2020.
- The Q3 2025 figure represents the lowest quarterly Non-Current Debt since Q1 2023.
- Year-over-year, Non-Current Debt increased in seven of the last eight quarters, with growth averaging 61.3%.
- The fastest year-over-year change in Non-Current Debt over five years came in Q1 2024 (growth of 253.2%), and the weakest in Q3 2025 (a decline of 71.5%).
- Business Quant data shows HUMA's Non-Current Debt at $66.43 million (Q2 2025), $64.67 million (Q1 2025) and $63.35 million (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Humacyte | 97.33 Mn | -101.11 Mn | -825,000.00 | -174,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 17.67 Mn |
| Jun 30, 2025 | 66.43 Mn |
| Mar 31, 2025 | 64.67 Mn |
| Dec 31, 2024 | 63.35 Mn |
| Sep 30, 2024 | 62.12 Mn |
| Jun 30, 2024 | 60.08 Mn |
| Mar 31, 2024 | 57.96 Mn |
| Dec 31, 2023 | 38.60 Mn |
| Sep 30, 2023 | 37.29 Mn |
| Jun 30, 2023 | 36.25 Mn |
| Mar 31, 2023 | 16.41 Mn |
| Dec 31, 2022 | 20.34 Mn |
| Sep 30, 2022 | 24.29 Mn |
| Jun 30, 2022 | 28.13 Mn |
| Mar 31, 2022 | 27.74 Mn |
| Dec 31, 2021 | 27.36 Mn |
| Sep 30, 2021 | 14.04 Mn |
| Dec 31, 2020 | 822,000.00 |
API Access
Humacyte Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=HUMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "HUMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=HUMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();